Table 3.
Inhibitor | Model | Time period and method of assessment | Hippocampal TUNEL counts | Hippocampal CA3 survivala | References |
---|---|---|---|---|---|
Caspase-1 | ESA | n.d. | n.d. | No effectb | [77] |
Caspase-3 | IAK | 4-24 h (WB, A) | n.d. | Increased | [60] |
ESA | n.d. | n.d. | Increased | [77] | |
Caspase-8 | IAK | 0-72 h (WB, A) | Reduced | Increased | [67] |
IAK | 0-72 h (WB) | Reduced | Increased | [61] | |
Caspase-9 | IAK | 4-72 h (WB, A) | Reduced | Increased | [64] |
IAK | 4-72 h (WB) | Reduced | Increased | [117] | |
ESA | n.d. | n.d. | Increased | [77] | |
viral p35 | SK | 8 h (A) | Reduced | n.d. | [66] |
Data are for CA3 subfield of the hippocampus. Inhibitors were: Ac-YVAD-cmk (caspase-1), z-DEVD-fmk (caspase-3), z-IETD-fmk (caspase-8) and z-LEHD-fmk (caspase-9).
Assessments made on either degenerating or remaining neurons in the CA3 part of the hippocampus.
Tendency to neuroprotection seen in dentate gyrus. Key: n.d., not determined; ESA, electrical stimulation of the amygdala; IAK, intra-amygdala kainic acid; SK, systemic kainic acid; WB, Western blot, A, enzyme assay.